PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Market Cap
$78.37M
P/E Ratio
-1.8
1Y Stock Return
-66.59%
1Y Revenue Growth
0.00%
Dividend Yield
0.00%
Price to Book
3.5
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
The heavy selling pressure might have exhausted for PDS Biotechnology (PDSB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Yahoo
PDS Biotechnology Corp (PDSB) reports a solid cash position amid increased R&D expenses and promising clinical trial updates.
Yahoo
EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation (PDSB) on Thursday reported a loss of $10.7 million in its third quarter. The East Princeton, New Jersey-based company said it had a loss of 29 cents per share. The results matched Wall Street expectations.
Yahoo
Conference call and webcast today at 8:30 a.m. Eastern TimePRINCETON, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and the development of infectious disease vaccines, today provided a business update and reported financial results for the third quarter of 2024. “Since our last update in August, we have been actively e
SeekingAlpha
PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsTom Johnson - LifeSci...
Finnhub
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results Conference call and webcast today at 8:30 a.m....
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PGEN | 40.14% | $228.91M | -28.00% | 0.00% |
MNKD | 37.54% | $1.89B | +84.91% | 0.00% |
KROS | 37.50% | $2.17B | +73.87% | 0.00% |
MGNI | 37.31% | $2.29B | +105.56% | 0.00% |
CRBU | 36.58% | $180.20M | -62.45% | 0.00% |
ALEC | 36.13% | $377.04M | -19.46% | 0.00% |
LMB | 35.54% | $1.12B | +157.63% | 0.00% |
PDLB | 34.38% | $304.77M | +38.12% | 0.00% |
AMSC | 34.31% | $1.25B | +257.53% | 0.00% |
CDXS | 34.29% | $345.86M | +121.35% | 0.00% |
NTRA | 34.29% | $21.40B | +200.46% | 0.00% |
GPRO | 34.08% | $179.52M | -67.23% | 0.00% |
RARE | 34.06% | $4.17B | +16.19% | 0.00% |
DAWN | 34.04% | $1.36B | +13.42% | 0.00% |
HIMS | 33.63% | $5.14B | +210.42% | 0.00% |
DUOL | 33.54% | $14.17B | +49.85% | 0.00% |
CHPT | 33.53% | $487.69M | -42.64% | 0.00% |
FWONA | 33.51% | $18.48B | +27.70% | 0.00% |
ATXS | 33.31% | $550.23M | +114.29% | 0.00% |
DMRC | 33.26% | $694.39M | -2.06% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PULM | -19.71% | $19.83M | +202.98% | 0.00% |
MCK | -15.66% | $78.15B | +35.51% | 0.42% |
LMT | -15.22% | $126.40B | +18.99% | 2.36% |
CAH | -14.12% | $28.64B | +12.14% | 1.70% |
COR | -13.76% | $47.48B | +21.20% | 0.86% |
HUSA | -13.30% | $16.69M | -11.56% | 0.00% |
CBOE | -11.92% | $21.46B | +15.84% | 1.11% |
BTCT | -10.59% | $42.61M | +353.33% | 0.00% |
TEM | -9.49% | $8.50B | 0.00% | 0.00% |
BEST | -8.93% | $31.65M | +3.88% | 0.00% |
CHD | -8.60% | $27.18B | +19.50% | 1.03% |
CYCN | -7.82% | $4.77M | -16.19% | 0.00% |
GO | -6.37% | $1.81B | -34.42% | 0.00% |
KR | -6.05% | $42.03B | +35.08% | 2.11% |
ACHC | -6.00% | $3.45B | -48.91% | 0.00% |
BACK | -5.89% | $1.76M | -32.90% | 0.00% |
PGR | -4.59% | $149.10B | +57.29% | 0.45% |
SMC | -4.33% | $383.35M | +97.26% | 0.00% |
DXYZ | -4.32% | - | - | 0.00% |
NTIC | -4.31% | $132.27M | +24.98% | 2.02% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GAN | 0.01% | $83.39M | +21.19% | 0.00% |
EDSA | 0.11% | $7.11M | -21.79% | 0.00% |
WMT | -0.21% | $696.11B | +66.69% | 1.38% |
RSG | -0.22% | $66.05B | +31.79% | 1.04% |
CVS | -0.33% | $70.18B | -18.08% | 4.72% |
LITB | 0.33% | $35.48M | -75.45% | 0.00% |
NTZ | -0.34% | $47.64M | -30.94% | 0.00% |
XEL | 0.37% | $41.42B | +15.91% | 3.12% |
MANU | 0.37% | $2.88B | -9.41% | 0.00% |
DOGZ | -0.42% | $614.77M | +1,372.26% | 0.00% |
ASPS | 0.52% | $22.36M | -80.26% | 0.00% |
VIRT | -0.54% | $3.17B | +110.38% | 2.60% |
LICY | 0.55% | $53.41M | -60.56% | 0.00% |
STG | -0.58% | $35.67M | +7.92% | 0.00% |
MMC | 0.65% | $108.41B | +10.89% | 1.37% |
IMRN | 0.71% | $10.31M | -5.04% | 0.00% |
MSDL | -0.76% | $1.83B | +0.66% | 7.26% |
GL | -0.81% | $9.18B | -8.60% | 0.86% |
WRB | -0.81% | $22.94B | +29.98% | 0.69% |
IDT | 0.85% | $1.26B | +74.67% | 0.30% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -41.77% | $388.04M | 1.43% |
VIXY | -25.61% | $195.31M | 0.85% |
UUP | -21.79% | $309.25M | 0.77% |
USDU | -21.17% | $201.97M | 0.5% |
TAIL | -14.70% | $67.98M | 0.59% |
CTA | -10.96% | $350.27M | 0.78% |
WEAT | -9.32% | $120.27M | 0.28% |
JBBB | -9.25% | $1.26B | 0.49% |
KMLM | -8.85% | $353.87M | 0.9% |
CCOR | -8.12% | $109.04M | 1.18% |
DBA | -7.72% | $755.88M | 0.93% |
JUCY | -6.96% | $324.29M | 0.6% |
EQLS | -6.72% | $76.08M | 1% |
DBO | -5.28% | $217.57M | 0.77% |
DBE | -5.25% | $50.13M | 0.77% |
CLOI | -5.08% | $715.40M | 0.4% |
KCCA | -3.09% | $220.51M | 0.87% |
USCI | -3.04% | $185.47M | 1.07% |
MINT | -2.70% | $11.62B | 0.35% |
GSG | -2.33% | $914.42M | 0.75% |
Current Value
$2.101 Year Return
Current Value
$2.101 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBIL | -0.09% | $637.70M | 0.15% |
DBC | 0.12% | $1.39B | 0.87% |
AGZD | -0.29% | $142.76M | 0.23% |
SOYB | 0.32% | $27.32M | 0.22% |
CORN | -0.34% | $61.12M | 0.2% |
PDBC | -0.59% | $4.40B | 0.59% |
FLTR | -0.63% | $1.79B | 0.14% |
BILZ | -1.47% | $563.02M | 0.14% |
BSCO | 1.56% | $2.35B | 0.1% |
BCI | 1.78% | $1.20B | 0.26% |
FLRN | 1.91% | $2.33B | 0.15% |
FTGC | 2.14% | $2.17B | 1.02% |
COMT | -2.14% | $829.06M | 0.48% |
GSG | -2.33% | $914.42M | 0.75% |
UNG | 2.55% | $908.80M | 1.06% |
DUSB | 2.66% | $797.63M | 0.15% |
MINT | -2.70% | $11.62B | 0.35% |
TBIL | 2.92% | $4.38B | 0.15% |
USCI | -3.04% | $185.47M | 1.07% |
KCCA | -3.09% | $220.51M | 0.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 50.60% | $70.59M | 0.5% |
XBI | 50.40% | $6.58B | 0.35% |
ARKG | 47.47% | $1.13B | 0.75% |
IWC | 46.68% | $933.99M | 0.6% |
IBB | 46.43% | $6.66B | 0.45% |
PEJ | 46.35% | $257.98M | 0.57% |
BUZZ | 46.26% | $59.71M | 0.75% |
SPGM | 46.18% | $877.62M | 0.09% |
AOA | 46.18% | $2.10B | 0.15% |
KOMP | 46.16% | $2.09B | 0.2% |
SMLF | 46.06% | $1.44B | 0.15% |
PBE | 46.06% | $258.53M | 0.58% |
PTH | 46.04% | $143.31M | 0.6% |
SCHB | 45.79% | $32.41B | 0.03% |
IWO | 45.77% | $12.56B | 0.24% |
DFAU | 45.56% | $6.79B | 0.12% |
AVUS | 45.55% | $7.71B | 0.15% |
VBK | 44.24% | $19.31B | 0.07% |
FBT | 43.92% | $1.11B | 0.56% |
DFAW | 43.92% | $525.81M | 0.25% |